Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects
Author:
Affiliation:
1. Merck Research Laboratories, Blue Bell and West Point, Pennsylvania, and Terlings Park, United Kingdom.
2. Clinical Pharmacology Associates, Miami, Florida.
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1177/009127002237994
Reference22 articles.
1. Pharmacokinetics of Ivermectin in Animals and Humans
2. Ivermectin detection in serum of onchocerciasis patients: relationship to adverse reactions;Njoo FL;Am J Trop Med Hyg,1995
3. Determination of ivermectin in human plasma by high‐performance liquid chromatography;Krishna DR;Arzneimittelforschung,1993
4. Protein binding and ivermectin estimations in patients with onchocerciasis
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Solubility and Thermodynamics of Ivermectin in Aqueous Mixtures of 1-Propanol/2-Propanol;Journal of Solution Chemistry;2024-09-02
2. Unlocking insights: Navigating COVID-19 challenges and Emulating future pandemic Resilience strategies with strengthening natural immunity;Heliyon;2024-08
3. Efficacy and safety of oral ivermectin in the treatment of mild to moderate Covid-19 patients: a multi-centre double-blind randomized controlled clinical trial;BMC Infectious Diseases;2024-07-22
4. Clinical practice guidelines for the diagnosis and treatment of scabies;International Journal of Dermatology;2024-06-23
5. Novel Patient‐Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use;The Journal of Clinical Pharmacology;2024-05-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3